Back to search
Gender Identity Disorder of Adult
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Gender Identity Disorder of Adult trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Gender Identity Disorder of Adult trials you may qualify forGLOW is a longitudinal mixed-methods study based at the NHV Gender Dysphoria Clinic in Region Skåne. It includes registry-based, qualitative interviews and repe…
Gender dysphoria is manifested by an internal tension between biological sex and gender, that is, by a non-congruence, in the subjects who suffer from it, betwe…
Transmasculine youth (female sex assigned at birth, male gender identity) who begin clinical gender affirming hormone therapy (GAHT) with testosterone (T) may e…
Because gender-affirming hormone therapy (GAHT) can lead to fertility impairment, current guidelines and treatment recommendations require that patients be info…
Introduction Gender-Affirming Care and Mental Health (GLOW) investigates the psychological, medical, and social factors that influence the outcomes of gender-af…
The goal of this clinical trial is to learn about the effects of different routes of estradiol administration on blood clotting in transgender women starting ge…
Transgender women living with Human Immunodeficiency Virus (HIV) may prioritize gender-affirming hormonal therapy over antiretroviral drug therapy. Hormonal the…